Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $.0001 per share
-
Shares outstanding
-
6.87M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
57M
-
Shares change
-
-3.06M
-
Total reported value, excl. options
-
$91.8M
-
Value change
-
-$3.75M
-
Put/Call ratio
-
0.09
-
Number of buys
-
15
-
Number of sells
-
-29
-
Price
-
$1.62
Significant Holders of Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) as of Q2 2025
60 filings reported holding VOR - Vor Biopharma Inc. - Common Stock, par value $.0001 per share as of Q2 2025.
Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (39.6M shares), 5AM Venture Management, LLC (6.36M shares), FMR LLC (2.09M shares), VANGUARD GROUP INC (1.92M shares), UBS Group AG (1.53M shares), JOHNSON & JOHNSON (1.07M shares), JANE STREET GROUP, LLC (526K shares), Sarissa Capital Management LP (508K shares), HRT FINANCIAL LP (475K shares), and RENAISSANCE TECHNOLOGIES LLC (468K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.